Literature DB >> 25130010

A case of mediastinal embryonal carcinoma successfully treated by integrative therapy.

Katsuhisa Kawanami, Norimitsu Wakao, Mitsuhiro Kamiya, Mikinobu Takeuchi, Atsuhiko Hirasawa, Emiko Takahashi, Keiji Sato.   

Abstract

Mediastinal embryonal carcinoma is rare, and the life prognosis of this disease is assumed to be relatively short. We encountered a case of mediastinal embryonal carcinoma for which we could perform radical surgical resection. The patient was male, aged 16 years, and acutely aware of back pain. Because the pain increased during the same year, he visited a local doctor, and an expanding neoplastic lesion was detected in the right thoracic wall by computed tomography (CT). Then he was referred to our institution. Magnetic resonance imaging (MRI) showed a dumbbell type tumor (Eden type 3) at the Th7/8 level. Malignant disease was suspected, so the authors planned and performed CT-guided biopsy. The result showed that this tumor pathologically corresponded to malignant peripheral nerve sheath tumor (MPNST). Therefore, chemotherapy was considered the main treatment. After 2 courses of chemotherapy, the tumor size decreased dramatically. The authors thought that radical resection is possible if there is no intrathoracic tumor dissemination as a result of a favorable response to chemotherapy. We thus perfomed surgical resection after we confirmed by a thoracoscopic exploratory thoracotomy that there was no intrathoracic tumor dissemination. Pathological findings were consistent with an embryonal carcinoma. Both the cutting ends of the thoracic wall and the epidural lateral sides of the excised lesion were negative for tumor cells. There is no image finding from the MRI and PET-CT suggesting metastasis or recurrence in the MRI and PET-CT 18 months after surgical resection. Therefore, the long-term vital prognosis can be expected in this patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25130010      PMCID: PMC4345714     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  8 in total

1.  NCCN clinical practice guidelines in oncology: testicular cancer.

Authors:  Robert J Motzer; Neeraj Agarwal; Clair Beard; Graeme B Bolger; Barry Boston; Michael A Carducci; Toni K Choueiri; Robert A Figlin; Mayer Fishman; Steven L Hancock; Gary R Hudes; Eric Jonasch; Anne Kessinger; Timothy M Kuzel; Paul H Lange; Ellis G Levine; Kim A Margolin; M Dror Michaelson; Thomas Olencki; Roberto Pili; Bruce G Redman; Cary N Robertson; Lawrence H Schwartz; Joel Sheinfeld; Jue Wang
Journal:  J Natl Compr Canc Netw       Date:  2009-06       Impact factor: 11.908

2.  Prognostic factors in patients with primary mediastinal germ cell tumors, a surgical multicenter retrospective study.

Authors:  Caroline Rivera; Alex Arame; Jacques Jougon; Jean-François Velly; Hugues Begueret; Marcel Dahan; Marc Riquet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-08-13

Review 3.  Multimodality treatment of germ cell tumors of the mediastinum.

Authors:  Kenneth A Kesler; Lawrence H Einhorn
Journal:  Thorac Surg Clin       Date:  2009-02       Impact factor: 1.750

4.  Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution.

Authors:  Shin-ichi Takeda; Shinichiro Miyoshi; Mitsunori Ohta; Masato Minami; Akira Masaoka; Hikaru Matsuda
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

5.  Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.

Authors:  Chang Hyun Kang; Young Tae Kim; Sang-Hoon Jheon; Sook-whan Sung; Joo Hyun Kim
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

6.  A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.

Authors:  Kenneth A Kesler; Karen M Rieger; Zane T Hammoud; Laura E Kruter; Susan M Perkins; Mark W Turrentine; Bryan P Schneider; Lawrence H Einhorn; John W Brown
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

7.  Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.

Authors:  Kenneth A Iczkowski; Samantha L Butler; Jonathan H Shanks; Deloar Hossain; Albrecht Schall; Isabelle Meiers; Ming Zhou; Kathleen C Torkko; Stacy J Kim; Gregory T MacLennan
Journal:  Hum Pathol       Date:  2007-11-28       Impact factor: 3.466

8.  Treatment strategies and prognostic factors of patients with primary germ cell tumors in the mediastinum.

Authors:  Ting Zhi Liu; Dong Sheng Zhang; Ying Liang; Ning Ning Zhou; Hong Fei Gao; Ke Jun Liu; Hai Ying Wu
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-18       Impact factor: 4.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.